Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis

Pathogens, Free Full-Text

How I treat and prevent COVID-19 in patients with hematologic malignancies and recipients of cellular therapies - ScienceDirect

Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation

Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis

Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis

Cancer in the Midst of COVID-19, A Report

Antibody response after vaccination against SARS-CoV-2 in adults with hematological malignancies: a systematic review and meta-analysis

SARS-CoV-2 DNA vaccine tested in animal model

Frontiers Will Host Genetics Affect the Response to SARS-CoV-2 Vaccines? Historical Precedents

PDF) Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis

Cancer in the Midst of COVID-19, A Report

COVID-19 vaccines and a perspective on Africa: Trends in Immunology

Cancer in the Midst of COVID-19, A Report